《1. Introduction》

1. Introduction

Additive manufacturing (AM) refers to a set of production technologies applied for the transformation of a three-dimensional (3D) digital model into a 3D physical object through successive material depositions in a layer-by-layer mode [1]. The advent of AM in the 1980s revolutionized the history of manufacturing. In comparison with conventional manufacturing approaches, AM has some obvious advantages. Conventional manufacturing consists of formative (molds) or subtractive (machining) techniques; thus, it requires costly infrastructures and multiple steps, resulting in seriously limited capability in terms of the timely implementation of modifications to the final product [2]. In comparison, due to its designability, AM allows for the fabrication of objects with intricate and complex geometries. For this reason, AM was applied in medical engineering soon after its development, and was rapidly developed to satisfy the needs of patients and clinicians [3,4]. Indeed, AM can be applied to fabricate medical devices used for diagnostics and surgeries, as well as orthoses and prostheses, in developing countries, where expensive devices are too costly [5,6]. The US Food and Drug Administration (FDA) published the first version of guidelines for the application of AM to produce medical devices in 2017 [7]. Anatomical models produced by AM provide benefits for both surgical planning and procedure training, particularly in cases of rare pathologies for which the customization of devices and processes play a critical role [8]

AM techniques have been applied in various areas for biomedical applications. In this article, we focus on the development of AM for the fabrication of drug delivery systems, medical implants, and medical devices—three types of products that are used on a particularly large scale at the clinical level. AM is competitive for the small-scale production of drugs requiring frequent dosage modification and complex geometries. It is advantageous for patient needs as well as for achieving tailored drug release profiles that cannot be easily obtained through conventional mass manufacturing processes [9–14]. AM can also be used to produce customized medical devices, allowing end products to be tailored specifically for the patient and realized at a very low cost. Nowadays, designing and printing personalized implants and prostheses has become the gold-standard method, and is a reliable solution for many patients who require specific constructs. AM has been widely used to fabricate dental parts [15], trauma medical implants, and orthopedic medical devices [16]. Tissue and organ printing is also an emerging area with significantly increasing interest from academia and industry [17]. Surgical applications include anatomical models [18], prostheses and orthoses [19], and surgical instruments [20]. Anatomical models aid pre-surgical planning and education [21]. Prostheses and orthoses are a broad category that includes implantable materials and external devices. Personalized surgical instruments are necessary to ensure accuracy and improve the efficiency of surgeries [22]. From these points of view, we summarize the applications of AM in the biomedical area in terms of pharmaceuticals, clinical implants, and medical devices. We also discuss and explain the advantages and limitations of AM technology when applied in these contexts. Finally, we discuss the challenges that still exist and provide future directions that may help the development of AM technologies toward large-scale biomedical production.

《2. Pharmaceuticals》

2. Pharmaceuticals

There are an increasing number of publications concerning the creation of pharmaceutical formulations such as oral (Fig. 1(a) [23]) and transdermal drugs using AM techniques [6]. Technologies of choice in this context include fused deposition modeling (FDM), stereolithography (SLA), binder jetting, powder-bed printing, semisolid extrusion, and inkjet printing [24]. Although these classes of drugs are still in their infancy, such manufacturing methods offer a few obvious advantages regarding dosage forms and drug formulation. For example, FDM enables the printing of thermolabile active pharmaceutical ingredients (APIs) at a relatively low temperature of 90 °C in comparison with traditional printing and allows a large variety of pharmaceutical-grade polymers to be processed in this way [25]. Inkjet printing has led to the development of a variety of biocompatible bioinks through the use of high-throughput screening methodology to identify 3D printable compounds [26]. AM technology is not only superior to traditional printing technology, but also appropriate for facilitating community pharmacies as well as other health-provision facilities on a small scale, due to its low cost. Recently, sustainable and massive manufacturing of drug-loaded filaments has been made possible [27] while conforming to the good manufacturing practices (GMP) of FDM printers and hot-melt extruders. These works indicate the impending transition from proof-of-concept demonstrations toward real-life applications.

《Fig. 1》

Fig. 1. Applications of AM techniques in pharmaceutics to fabricate different types of drug formulations. (a) Tablets of oral medicines. Reproduced from Ref. [23] with permission of John Wiley & Sons, ©2015. (b) Patches of transdermal drugs. Reproduced from Ref. [43] with permission of John Wiley & Sons, ©2011. (c) Microneedles of transdermal drugs. Reproduced from Ref. [47] with permission of John Wiley & Sons, ©2016.

AM is particularly favorable to promote the drug release of unreleasable soluble compounds. A novel AM technology, which can be categorized as instant powder extrusion, was exemplified by producing itraconazole-loaded printlets as amorphous solid dispersions that could be instantly drawn out of powdered materials. This quick-release technique also obviates the increasingly longterm development time for filament-production-based requirement in FDM [28]. Recent studies have reported on the intensified ability of AM to create lipid-oriented conceptions in order to strengthen the drug release of drugs that are insoluble or nearly insoluble in water [29].

Due to its advantages of accurate and flexible material spatial distribution, AM has gained widespread application in multi-drug combinations. For example, Pereira et al. [30] managed to print a cardiovascular polypill containing four different drug components. In a recent study, Awad et al. [31] announced the successful production of 3D-printed, millimeter-scale pellets ("mini-printlets”) that contain two spatially isolated drugs (paracetamol and ibuprofen). By changing the polymer, the dual mini-printlets can attain customized drug release. A kind of drug achieved immediate release from the matrix, while the second patterns of the drug can gain a long acting effect through the use of ethyl cellulose. In terms of application routes to the body, both oral and transdermal drugs have potential for development via AM technologies.

《2.1. Oral drugs》

2.1. Oral drugs

AM has been applied in pharmaceutics to produce oral drugs with complicated structures and elaborate shapes, which are cost-ineffective or impossible to be achieved through traditional procedures [32]. A wide spectrum of AM techniques can be used to easily manufacture dosage forms with complex geometries, such as microstructured formulations with an internal channel [33], honeycomb [34], network [35], or gyroid forms [9]. The drug release profiles can be tailored by adjusting the morphology and dimension of 3D-printed materials and architectures, such as through composite multilayered or shell–core formulations, to deliver at least one type of API with variable rates due to the designed differences in the specific structure and sequence of layers [36,37]. Furthermore, the creation of complex scaffolds and matrices makes the incorporation of drug-loaded formulations or APIs possible. For example, such a feature might help in the creation of carriers such as capsules with specific compartments, which can incorporate various types of APIs and then release them independently [38]. In addition, this feature can assist in the production of modifiable containers for enclosing drug-loaded alginate beads [39], polymeric nanocapsules [40], or selfnanoemulsifying drug delivery systems [41].

In comparison with traditional injection molding (IM), AM could be better at manufacturing customized capsules in small individualized batches. By 3D printing personalized oral solid dosage forms and multi-particulate systems, the advantages of both these features can be exploited in a synergistic way, providing better dispersion and distribution in the gastrointestinal tract, as well as dose accuracy and convenience. Processing carrier matrices filled with drug-loaded solutions or suspensions is another interesting feature of AM [42]. This approach can guarantee a high dose accuracy and be time effective.

《2.2. Transdermal drugs》

2.2. Transdermal drugs

Applied together with 3D scanning, high-precision AM has been leveraged to manufacture automatically adaptable patches, and has hence been applied in personalized transdermal drugs (Fig. 1(b) [43]). A study highlighted SLA as a method that outperforms FDM in producing an antiacne device containing salicylic acid, which showed improved thermal stability, drug-loading capacity, and resolution [44]. The device also showed faster drug diffusion in comparison with ethnodrugs, while personalized medicine printing was facilitated by applying a 3D scan of an area to determine the anatomical requirements of the patient [44]. Based on the same concept, the fabrication of a personalized polycaprolactone (PCL) dressing loaded with antimicrobial metals was implemented against scanned templates of a target wound, and demonstrated prolonged release kinetics of the antimicrobials, which is desirable in clinical practice in order to reduce medical intervention to the minimal level [45]. In another study, electrohydrodynamic (EHD) printing was used to fabricate antimicrobial PCL/polyvinylpyrrolidone patches, enabling the release kinetics of loaded tetracycline hydrochloride to be tailored by adjusting the fiber pattern and composition [46].

Transdermal drug delivery has been implemented with microneedles as a minimally invasive approach to improve drug permeation over the skin barrier (Fig. 1(c) [47]). AM techniques have been applied to generate various types of functionalized microneedles. In one study, insulin-xylitol coatings were inkjet printed on SLAprinted pyramid-shaped resin microneedles, which exhibited rapid insulin release while retaining protein integrity [48]. In another study, continuous liquid interface production was applied as an alternative method for coating polyethylene glycol (PEG)-based microneedles with model proteins, and permitted spatial control of the coating pattern [49]. In an attempt to optimize the geometrical properties of the microneedles, chemical etching of the biodegradable poly(lactic acid) (PLA) arrays was adopted as a post-fabrication phase [50]. A microneedle-customized splint was used to achieve personalized drug delivery that was adaptable for the curvature of skin in order to cure trigger finger [51]. A bioinspired needle was designed using AM to mimic the barbs of honeybee stingers with the intention of reducing the extraction and insertion forces during percutaneous application by differentiating the barb design parameters [52].

《3. Medical implants》

3. Medical implants

In the field of clinical implanting, there has been a growing development of the shape and function design that allows a considerable degree of matching of foreign objects with internal structures and tissues of the human body, while improving their functions. AM can bridge the difference between biological matter and engineering projects by composing architectures with biocompatibility and bioactivity, which utilize the unique attributes of materials to enhance the combination of tissue regeneration and the implant, along with the surrounding tissues. Current radiological imaging approaches, such as computed tomography (CT), can create an accurate computer-aided design (CAD). Such a design can act as a model for AM, in order to generate implants with an ideal fit to implant-position. Mechanical load bearing is usually provided by hard structures, while biological and chemical functions ranging from muscular contraction to neural processing are mainly provided by soft constructs or structures.

《3.1. Hard-structure implants》

3.1. Hard-structure implants

Accurate control of the internal pore structure of porous architectures can be achieved with AM, which allows complex geometries to be manufactured with repeatability. Among the different approaches, selective laser melting (SLM) can be regarded as a very promising route for the fabrication of medical devices due to its versatility and high accuracy, as well as the good surface finish and structural integrity of the fabricated implants [53]. SLM is an excellent choice for creating the small features (< 500 μm) that are typically present in spinal fusion implant devices.

Hard-structure implants, which play an indispensable part in managing patients undergoing orthopedic injuries, can help with aspects of recovery such as alignment, structural integrity, and motion capability. Most implants are available in standard sizes for fitting patients. However, patients at the extreme edge of anatomical variability, or those with specific disorders, may require customized implants in order to ensure a correct fit [54]. Similar to the processes used in dentistry, CAD models of patients are created based on the patients’ anatomical structure, as determined through radiological imaging, making it possible to design and fabricate custom-fit implants with AM. Orthopedic implants require integration with (or the regeneration of) the patients’ own bones to create successful tissue support and prevent failed implants. More specifically, customized orthopedic implants seamlessly incorporate the continuous growth of the bone and the designed flexibility in order to prevent stress shielding. Such systems can be fabricated via the selective laser sintering of titanium alloy (Ti–6Al–4V). Cranial reconstruction implants can be made of polyether ether ketone, stainless steel, and titanium, and can be fabricated in advance and then customized on demand for individual patients. In a recent study, Zhang et al. [55] described titanium–copper alloys with a fully equiaxed fine-grained microstructure that displayed promising mechanical properties during AM, in addition to excellent antibacterial properties, good biocompatibility, and corrosion resistance. These materials are interesting for application in the biomedical industry (Fig. 2) [55].

《Fig. 2》

Fig. 2. (a) Optical micrograph of an as-printed Ti–6Al–4V alloy. Coarse columnar grains can be clearly seen; (b) optical microstructures of an as-printed Ti–8.5Cu alloy show fine, fully equiaxed grains along the building direction instead, under the same manufacturing conditions. Layer boundaries are highlighted by arrows. Reproduced from Ref. [55] with permission of Springer Nature, ©2019.

A small number of factors related to an implant’s structure and composition can drive its capability to promote bone regeneration. Porosity is a crucial property to ensure the penetration of an implant among tissues and vessel ingrowth [56]. High-resolution AM can be used to create porous implants, with an interwoven bone mesh used to secure the implant into the neighboring bone tissues. Moreover, AM materials with bio-absorbability and osteoinductivity, such as calcium phosphate cement, are effective in decelerating bone growth [57]. Last but not least, implants can concentrate and enhance the effects of drugs and influential growth factors, such as bone morphogenetic protein or vascular endothelial cell growth factor, to ensure local and sustained release at the implantation location. In this way, such implants promote systematic exposure to those compounds [58]. Furthermore, small-scale therapeutics have been called for, putting emphasis on cost-efficiency [59]. Ren et al. [60] reported the use of a general synthetic orthogonal assembly approach to build 3D multilayercrossed metal oxide nanowire arrays in a controllable manner. This enabled the realization of nanodevices with tailored conductivity, porous structure, and high surface area, which hold promise for application in the repair of spinal cord injury (Fig. 3) [60]. Researchers have also shown the potential of light-curing AM to produce patient-specific dentures with unique antibacterial properties via the inclusion of titanium dioxide (TiO2) within a polymethyl methacrylate [61].

《Fig. 3》

Fig. 3. Transmission electron micrograph of the porous structure formed by interwoven crystalline semiconducting tungsten trioxide (WO3) nanowires that are "welded” at the crossing points. Reproduced from Ref. [60] with permission of Springer Nature, ©2020.

AM is well-established as a feasible and accurate approach for fabricating durable artificial implants that are comparable to those produced using conventional manufacturing techniques and materials [62]. Close collaboration between implant engineers and surgeons is necessary in order to produce patient-specific implants using AM. In the planning phase of such implants, engineers create a design based on the surgical requirements specified by surgeons, including a porous scaffold for bone ingrowth, the site of bone fixation, optimal alignment of the necessary implants, the bone defects that require reconstruction, and the specific surgical approach. In this way, the desired geometry can be fabricated through AM to provide the required physical and mechanical properties for each surgical application.

《3.2. Soft-structure implants》

3.2. Soft-structure implants

Nowadays, there is an increasing demand for the bioprinting of tissues and organs. Recreating the complex structures of a tissue using cell-compatible materials has been a major challenge. For example, in air-breathing vertebrates, the circulatory and pulmonary systems contain separate networks of channels that intertwine but do not intersect with each other. These architectures are highly complex to mimic, and are especially demanding in terms of microfabrication. AM technologies have been successfully applied to fabricate soft-structure implants for generating tissue constructs, such as heart tissue, kidney, liver, blood vessel, ear, and cartilage. However, further research is still needed in order to decrease the gap between a fully 3D-printed anatomical model and living, biological, soft structures. In fact, most 3D printing materials lack the realism to adequately mimic soft human biological tissue. Thus, postprocessing may be necessary in order to soften structures that have been printed using appropriate precursor materials.

Grigoryan et al. [63] showed that natural and synthetic food dyes can be used as photoabsorbers to enable the stereolithographic production of hydrogels containing intricate and functional vascular architectures. Using this approach, they demonstrated functional vascular topologies for studies of fluid mixers, valves, and systems for intervascular transport, nutrient delivery, and host engraftment. Kidney organoids derived from human pluripotent stem cells have glomerular- and tubular-like compartments that are largely avascular and immature in static culture. Homan et al. [64] and Johnson et al. [65] demonstrated that vascularized kidney organoids that were cultured under flow expanded their endogenous pool of endothelial progenitor cells and generated vascular networks with perfusable lumens surrounded by mural cells (Fig. 4(a) [64]).

For the treatment of myocardial infarction, 3D printing of mesenchymal stem cells has been shown to be effective in decreasing the scar tissue formation and collagen deposition after infarction [66]. However, the restricted transport of cell-secreting therapeutic cytokines limits the therapeutic efficacy at the implantation site. It has been found that the gel-tissue interface can be effectively removed using a developed cross-linked poly(ethylene glycol) dimethacrylate-based microchanneled hydrogel patch, which can act as a physical barrier to biomolecular transport and thereby assist in the transport of cytokines. In recent years, a considerable amount of research has addressed the dynamic changes in the cell environment, which impact tissue functions. As a result, microfluidics-based cell-culture platforms have been improved to become effective experimental tools for organ bioengineering. The human hepatoma cell line (HepG2), human umbilical vein endothelial cells (HUVECs), and PCL were used to develop a 3Dprinted liver-on-a-chip platform [67]. A bioartificial renal tubule device embedding human renal stem/progenitor cells was demonstrated in the context of kidney research [68]. The researchers described the dramatically improved functions of the liver-on-achip and heterotypic cell types. Microfluidics have also been used to print a nervous-system-on-a-chip (Figs. 4(b)–(e) [65]), which was depicted by Johnson et al. [65] as a model to investigate a viral infection of the nervous system. The microchannels were manufactured by utilizing micro-extrusion AM to achieve compartmentalized chambers and axonal alignment for cell isolation. Future research on these systems will include the development of new strategies for the treatment of neurological disorders and further investigation of the in vitro functionality of personalized 3Dprinted models.

《Fig. 4》

Fig. 4. (a) Developing kidney organoids cultured in vitro under high fluid flow exhibit enhanced vascularization during nephrogenesis. (b) 3D printing of a model nervoussystem-on-a-chip: (i) channel printing; (ii) seal printing; (iii) chamber printing. (c) Schematic of a 3D-printed nervous-system-on-a-chip with (i) peripheral nervous system neurons, (ii) Schwann cells, and (iii) terminal cell junctions. (d) Circular pattern of silicone microchannels for axonal guidance in a plastic dish. (e) Nervous-system-on-a-chip system. (a) Reproduced from Ref. [64] with permission of Springer Nature, ©2019; (b–e) reproduced from Ref. [65] with permission of the Royal Society of Chemistry, ©2016.

Although there have been many successful examples of bioprinting, several problems remain to be solved. The long-term viability of cells is one of the major issues. Another issue involves improving the control of cell proliferation in order to obtain abundant supporting and functional cells and tissue homeostasis. Cell type is of great importance, given that the cells must be able to reconstruct the building blocks of organs with multiple sizes, architectures, and functions. In addition, the tissues applied in AM should be capable of surviving shear stress and pressure during printing, as well as the possible presence of harmful chemical compounds and non-physiological pH values. Apart from the conditions mentioned above, scaffold materials should also satisfy precise standards, such as appropriate structural and mechanical properties, non-toxic byproducts, and biocompatibility, given that cell proliferation, adhesion, and migration will be critically affected by these aspects [69].

Special attention has been paid to the use of AM in craniofacial reconstructive surgery, since this technology can precisely replicate individual facial features. Cartilage from patients and silicone prostheses can commonly replace regions of the ears that have been damaged by traumatic events or congenital issues. However, such solutions are costly, and patients must usually undergo multiple visits to the hospital. Furthermore, it is difficult to achieve a shape that fits the defect site perfectly without resectioning healthy tissues or using extra fillers. Fortunately, composite structures have been shown to be capable of satisfying expectations in terms of both the geometry and anatomy of the native ear. Scanning printing polishing casting (SPPC) was used to produce artificial ears with low-cost soft tissue [70]. Unkovskiy et al. [71] produced an artificial nose and applied post-process coloring and sealing in addition to silicon-based implants. As a result, the defect of the patient was fitted well. An infant was also implanted with a customized, collapse-resistance PCL-based bioresorbable tracheal splint [72]. AM can be particularly helpful for producing nonstandardized implants for pediatric patients. All of the abovementioned studies show that, with the development of AM technology, printed organs are moving toward finer and more complex structures.

Composites that contain multiple types of materials are a promising route toward the production of human tissues using AM techniques, since none of the currently available materials are likely to be able to fully mimic elastic and biological tissues. Multi-material composites may be designed based on the capacity of a selected biological material to replicate the mechanical properties and architecture of native human tissues [73].

《4. Medical devices》

4. Medical devices

A medical device is basically a tool used to check and treat patients. Patients have direct contact with such a tool. However, a medical device is not meant to be inside the body throughout the duration of the treatment or examination. Different types of medical devices have been fabricated and developed by AM for both diagnosis and treatment purposes.

《4.1. Diagnostic tools》

4.1. Diagnostic tools

Better evaluation and assessment, and more accurate diagnosis, have been enabled by the application of AM. AM also facilitates the visualization of patient-specific organ anatomy. The amount of information available for preoperative planning has been dramatically increased beyond the features of an individual organ. Therefore, it is believed that surgical planning and education is one of the most important fields for the application of AM technologies. The manufacturing of liver models is one such example. Growing transplantation needs and the limited number of cadaveric livers are stimulating the demand for organs from healthy donors. Zein et al. [74] described transparent models with appropriate colorcoded vasculature. Six models of livers from six patients were prepared, and illustrated identical geometrical and anatomical characteristics between the native and printed organs. CT scans were used to visualize the 3D anatomy of the livers, tumors, blood vessels, and organ contours in the patients. Silicone was used to fill and assemble a multilayered structure. Successful subsequent laparoscopic right hemihepatectomies were then undergone by the patients. Another case of preoperative planning based on 3Dprinted phantoms occurred in the context of renal malignancy modeling [75]. SLA AM was used to produce five physical phantoms of clear translucent nephrons with red translucent suspected malignancies. The patients then underwent successful partial nephrectomies. It was forecasted that the cost of manufacturing a life-sized liver model with a transparent parenchyma, colorcoded vascularization, and tumor sites would be less than 150 USD [76].

To benefit pediatric laparoscopic pyeloplasty, silicon models of the ureter, renal pelvis, and kidney have been improved [77]. This operation is extremely challenging due to the delicate tissues, finer sutures, and smaller workspace it entails. Therefore, it demands strong training. Medical imaging modalities were used to test printed models, such as two-dimensional (2D) and 3D ultrasound and magnetic resonance imaging (MRI). The production cost was less than 100 USD and required several hours of labor.

In recent years, AM models have been used in the field of cardiology, with a focus on patients with congenital heart disease (Fig. 5(a)[78]). Such pediatric models hold strong educational value. They can present complicated anatomical concepts, such as the spectrum of heterotaxy syndromes, malalignment-type ventricular septal defects, and double-outlet right ventricles. 3D-printed models make the treatment of aortic diseases comparatively easier because they can reproduce the aortic anatomy and diameters exactly. AM has been successfully applied for patients suffering from hypertrophic cardiomyopathy and cardiac tumors; the lesion size serves as the major parameter to determine strategical choices of surgery, such as a heart transplant or a total resection. In this framework, the implementation of 3D models can enable a rapid comprehension of anatomical heart defects, including complicated aspects such as crisscross atrioventricular connections [79].

《Fig. 5》

Fig. 5. Medical devices classification. (a) Actual-size 3D model of the heart and great vessels of a 1-day-old male patient with pulmonary atresia, confluent pulmonary branches connected to the pulmonary artery, and multiple aortopulmonary collateral arteries (MAPCAs). Reproduced from Ref. [78] with permission of Elsevier, ©2015. (b) 3D-printed partial hand prosthesis [83]. (c) Adjustable stiffness ankle-foot orthosis [19]. (d) Two printed replicas of PLA surgical prototypes. Reproduced from Ref. [20] with permission of Elsevier, ©2014.

AM has also been used in the context of the growing number of patients with degenerative issues. A 3D-printed brain system was demonstrated by Marks et al. [80], showing different phases of Alzheimer’s disease. This system was used as an educational tool to assist researchers in the understanding of the progressive degenerative changes of the hippocampus and cerebral cortex. Magnetic resonance images of the brains of five patients were captured and printed. The time required to print each model ranged from 15 to 20 h. The authors concluded that the models could not yet be applied for diagnosis, but could be used for the purpose of education.

《4.2. Therapeutic tools》

4.2. Therapeutic tools

Given the clinical applications, we categorize therapeutic instruments into prostheses, orthopedic devices, and surgical tools. Prostheses specifically refer to artificial limbs that are attached to the outside of the body, such as prosthetic hands, arms, and lower limbs. Orthopedic devices are mainly auxiliary tools related to treatment, such as plaster and splints. Surgical tools are used during operations, and include both surgical operation tools whose basic design is based on traditional instruments, such as surgical tweezers, and other tools that are customized for the surgical treatment of specific diseases, such as laparoscopic or endoscopic instruments.

4.2.1. Prostheses

3D structures produced by AM can be carefully designed to achieve high strength-to-weight ratios compared with those of many conventional solid structures. Such structures require less material than a fully solid structure to achieve a similar performance, making them potentially resource efficient. Indeed, reducing the weight is a priority in prosthetic applications. Pham et al. [81] deliberately introduced apparent imperfections into 3Dprinted plastic and metal lattices to make them stronger. This strategy mimics on a larger scale the imperfections of structure and composition that can enhance the mechanical performance of normal crystalline materials.

It is a traumatic event to lose a limb, whether from an accident, in combat, or as a result of a calculated decision to address a growing tumor or other deteriorating illness. Amputation can leave a lasting aftermath in a patient’s quality of life, and can cause concerned families and friends to suffer as well. In this regard, longlasting "peg-leg” and "hand-hook” prosthetics, which can meet mechanical demands, can provide adequate recovery of gross motor functions such as standing and walking. However, artificial arms and legs can be improved by means of modern AM fabrication technologies. Based on such technologies, numerous producers of rapid bespoke 3D printing could be established, that could produce cost-efficient and functional prosthetics for amputees. This development would inevitably affect the future market for orthotics, including both large and mid-sized commercial companies.

 Herbert et al. [82] developed a simple prosthetic foot with AM, using an efficient and simple fabrication technology that patients were found to be comfortable with. Zuniga et al. [83] prepared a low-cost 3D-printed hand for children with upper-limb reductions (Fig. 5(b) [83]). Subsequent survey results indicated that the prosthetic hand could have a positive impact on children’s quality of life in the context of multiple activities at home and at school.

4.2.2. Orthoses

AM has demonstrated its capability to fabricate custom foot orthoses, ankle-foot orthoses (Fig. 5(c) [19]), and wrist splints [84] with good fit and adequate strength in limited clinical assessments. However, multiple barriers remain to be dealt with to enable the adoption of AM in the field of orthotics. These barriers include: a lack of clinical and design interfaces for an AM system [85]; uneconomic throughput and material cost; and limited material strength [86]. Multiple software platforms are being applied in research to process the 3D geometry of an orthosis. With the goal of realizing these geometries in an effective manner, a software platform has been made specifically for the AM of orthotics. AM can also increase the aestheticism, complexity, and functionality of the realized components, thus overcoming clinical barriers to better efficacy and fit, and enabling a faster delivery time (e.g., same-day visits). Fabrication cost and time are viewed as the two major barriers to the application of AM in orthoses. In fact, AM requires a relatively high initial investment in equipment. As the AM industry and AM technologies improve, however, it is expected that the price of AM equipment will decrease, while the material deposition rate increases. The application of AM techniques can in turn generate better design. For example, sparse structures and the optimization of topology will guarantee that a material is applied in an effective way. Moreover, it is easy to incorporate design tools into the workflow of orthotists. Durability and safety are extremely important in orthoses, which are applied under repeated loading and require both fatigue strength and ultimate strength. Although the majority of studies on the AM of orthoses have been carried out under laboratory conditions, there is need for long-term research to explore achievable durability. For example, thermoplastic materials can be reinforced with carbon fibers [87] in order to obtain more robust and durable components.

4.2.3. Surgical tools

Advancements in radiological imaging have allowed patientanatomy-based CAD reconstructions to be obtained, which offer patient-specific design and fabrication, as well as customized surgical devices. At present, most surgical equipment is designed to be effective for a wide range of patients, albeit in a largely unspecific way. Nonetheless, unique anatomical features or extremely complicated medical processes can benefit from customized devices that permit a more controlled and simplified operation, which decreases the risk of complications [88]. AM can be used not only to produce efficient devices by quickly transforming a CAD design into usable tools to meet the continuously increasing demands of large-scale organizations such as hospital operating rooms, but also to reduce the cost of tools. A study revealed that 3D-printed retractor based on PLA could perform in comparison with its stainless counterpart, at one tenth of the cost (Fig. 5(d) [20]). As long as the technology can be carried out on a large scale, such systems result in great cost saving. Even in extreme environments such as long-term space missions, 3D-printed surgical tools have proved effective [89]. In fact, the cost-efficiency of 3D-printed surgical devices in low-income countries and organizations makes such devices both feasible and extremely practical.

AM technology has been already used for the creation of personalized surgical operation tools. Navajas and ten Hove [90] reported an example of cooperating with the patient’s operation via AM for customizing trocar-cannula fabrication of a transconjunctival vitrectomy, which is a procedure in which the gel-like material of the eye is substituted with saline solution. Under such circumstances, there is no change in the functionality of the trocarcannula. However, with AM technology, the size of the trocarcannula can be customized based on the surgical instruments used in this process. Walker et al. [91] developed a similar method for the design of measuring tools to estimate the probe size applied in a lumpectomy, which is a breast cancer removal procedure. The general design of the measuring tools, which have a handle with a sphere on top, is similar to that of a probe. However, with AM, the diameters of the spheres can be adjusted within the range of 1.5–5 cm, as determined by the needs of each patient. In this way, an appropriate probe can be selected while preventing the unnecessary sterilization of probes with the wrong size.

AM can also be applied to fabricate extra parts. Based on a study by Walter et al. [92], a cap can be added over a traditional colonoscope to improve the view of the instrument and to identify the presence of polyps in the colon. AM can be used to customize the size of the cap for various colonoscopies. Ko et al. [93] pointed out that the cap is added to the traditional shape of a gastroscope, and differs depending on the procedure to be implemented. For example, esophageal biopsies have been performed with a cap with a wide end. Steinemann et al. [94] customized a space holder to be inserted in order to expose the esophageal mucosa and assist in a novel laparoscopic surgical procedure aimed at resecting the distal esophageal mucosa.

Using AM, innovative instruments have been designed for treatment or to offer palliative care for various kinds of cancer [95]. A new type of cheap thermo-coagulator was introduced by Chen et al. [96] for the treatment of cervical neoplasia, which is an anomalous growth of cells in the female cervix. Meanwhile, an MRI-compatible device was proposed by Menikou et al. [97], which applied thermal ablation. In a study by Peikari et al. [98], the area of interest was placed in direct contact with a 3D-printed device for a brachytherapy. Dikici et al. [99] proposed a new device to implement a specific gynecological surgery that involved removing the uterus with a laparoscopic approach. Rugg et al. [100] used AM to fabricate a tailored handpiece to hold a scanning fiber endoscope, which is a specific instrument applied to obtain dental images without using X-rays. Traeger et al. [101] proposed a device to implant cell sheets after removing gastrointestinal tumors, which involved AM of the cell-sheet carrier. Last but not least, an individualized robot for minimally invasive surgery (overtube system) was presented by Zizer et al. [102] to make it suitable for a particular surgery during which a gastrointestinal tumor was removed and also performed on the laparoscopic environment to remove small kidney tumors [103].

《5. Conclusions and prospects》

5. Conclusions and prospects

In this article, we summarized the applications of AM in various biomedical areas. AM is becoming a widely accepted technique in medicine, as it offers patient-specific design, high complexity, on-demand and cost-effective fabrication, and high productivity. As shown in Table 1 [9,19,31–44,53,60,62–64,69,74–82,84–86,88], drugs designed using AM have controlled release kinetics and achieve good efficacy. Medical implants created by AM can improve the safety and accuracy of treatment. Through this advanced technology, preoperative models can help surgeons to plan surgeries, and the generated surgical tools can help to solve certain surgical problems and shorten the operation time. Prostheses and orthoses provide patients with personalized devices to recover certain functions and improve their quality of life.

Although AM has been successfully used in many medical applications, there are still issues that need to be addressed, as summarized in Table 1 [9,19,31–44,53,60,62–64,69,74–82,84–86,88]. Optimization of the key processing parameters of AM and the development of a wider selection of biomaterials are necessary in the future.

《Table 1》

Table 1 Summary of the main characteristics, advantages and limitations, and challenges and future directions of AM technologies in clinical applications of pharmaceuticals, medical implants, and medical devices.

《Acknowledgements》

Acknowledgements

This work is sponsored by the National Key R&D Program of China (2018YFB1105504) and the National Natural Science Foundation of China (81572093). This work is also supported by the funding support from Beijing Laboratory of Biomedical Materials and start-up fund from Beijing University of Chemical Technology.

《Compliance with ethics guidelines》

Compliance with ethics guidelines

Chunxu Li, Dario Pisignano, Yu Zhao, and Jiajia Xue declare that they have no conflict of interest or financial conflicts to disclose.